Europe Stroke Management Market Analysis (2017-2023) - Product Image

Europe Stroke Management Market Analysis (2017-2023)

  • ID: 4456908
  • Report
  • Region: Europe
  • 90 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 4

FEATURED COMPANIES

  • ABBOTT
  • B. Braun Melsungen AG
  • Bristol-Myers Squibb.
  • Cardinal Health
  • General Electric (GE)
  • GlaxoSmithKline plc
  • MORE
The Europe Stroke Management Market would witness market growth of 6.8% CAGR during the forecast period (2017 - 2023). Stroke is a medical emergency which occurs when the flow of the blood is restricted to the brain and as a result, brain cells start dying. Rise in incidence and prevalence of chronic diseases has been a major factor that is responsible for the growth of the stroke management market. Additionally, growing geriatric population, which is highly susceptible to strokes, growing diabetic population and usage of tobacco are other factors that are driving the growth of the market. However, the cost associated with the treatment and stringent government regulations pertaining to the approval of new and advances devices and drugs would limit the market growth.

Based on Type, the market report segments the market into Diagnostics and Therapeutics. Diagnostics type includes Computed Tomography Scan (CT Scan), Echocardiography Magnetic Resonance Imaging (MRI), Carotid Ultrasound, Cerebral Angiography, Electrocardiography, and Other Diagnostics. Therapeutics includes Tissue Plasminogen Activator, Anticoagulant, Antiplatelet, and Antihypertensive. Based on Application, the market report segments the market into Ischemic Stroke and Haemorrhagic Stroke Based on Countries; the Stroke Management market segments the market into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the Stroke Management Market. Key companies profiled in the report include B. Braun Melsungen AG, Boston Scientific Corporation, Teleflex Inc., Cardinal Health, Medtronic Plc., General Electric (GE), Merck Sharp & Dohme Corp., ABBOTT, GlaxoSmithKline plc, and Bristol-Myers Squibb.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • ABBOTT
  • B. Braun Melsungen AG
  • Bristol-Myers Squibb.
  • Cardinal Health
  • General Electric (GE)
  • GlaxoSmithKline plc
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Stroke Management Market, by Type
1.4.2 Europe Stroke Management Market, by Application
1.4.3 Europe Stroke Management Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.2 Drivers, Restraints and Opportunities
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Europe Stroke Management Market
3.1 Europe Stroke Management Market by Type
3.1.1 Europe Diagnostics Market by Country
3.1.2 Europe Diagnostics Market by Type
3.1.2.1 Europe Computed Tomography Scan (CT Scan) Market by Country
3.1.2.2 Europe Echocardiography Market by Country
3.1.2.3 Europe Magnetic Resonance Imaging (MRI) Market by Country
3.1.2.4 Europe Carotid Ultrasound Market by Country
3.1.2.5 Europe Cerebral Angiography Market by Country
3.1.2.6 Europe Electrocardiography Market by Country
3.1.2.7 Europe Other Diagnostics Market by Country
3.1.3 Europe Therapeutics Market by Country
3.1.4 Europe Therapeutics Market by Type
3.1.4.1 Europe Tissue Plasminogen Activator Systems Market by Country
3.1.4.2 Europe Anticoagulant Market by Country
3.1.4.3 Europe Antiplatelet Market by Country
3.1.4.4 Europe Antihypertensive Market by Country

Chapter 4. Europe Stroke Management Market by Application
4.1 Introduction
4.1.1 Europe Stroke Management for Ischemic Stroke Market by Country
4.1.2 Europe Stroke Management for Haemorrhagic Stroke Market by Country

Chapter 5. Europe Stroke Management Market by Country
5.1 Introduction
5.2 Germany Stroke Management Market
5.2.1 Germany Stroke Management Market by Type
5.2.1.1 Germany Diagnostics Market by Type
5.2.1.2 Germany Therapeutics Market by Type
5.2.2 Germany Stroke Management Market by Application
5.3 UK Stroke Management Market
5.3.1 UK Stroke Management Market by Type
5.3.1.1 UK Diagnostics Market by Type
5.3.1.2 UK Therapeutics Market by Type
5.3.2 UK Stroke Management Market by Application
5.4 France Stroke Management Market
5.4.1 France Stroke Management Market by Type
5.4.1.1 France Diagnostics Market by Type
5.4.1.2 France Therapeutics Market by Type
5.4.2 France Stroke Management Market by Application
5.5 Russia Stroke Management Market
5.5.1 Russia Stroke Management Market by Type
5.5.1.1 Russia Diagnostics Market by Type
5.5.1.2 Russia Therapeutics Market by Type
5.5.2 Russia Stroke Management Market by Application
5.6 Spain Stroke Management Market
5.6.1 Spain Stroke Management Market by Type
5.6.1.1 Spain Diagnostics Market by Type
5.6.1.2 Spain Therapeutics Market by Type
5.6.2 Spain Stroke Management Market by Application
5.7 Italy Stroke Management Market
5.7.1 Italy Stroke Management Market by Type
5.7.1.1 Italy Diagnostics Market by Type
5.7.1.2 Italy Therapeutics Market by Type
5.7.2 Italy Stroke Management Market by Application
5.8 Rest of Europe Stroke Management Market
5.8.1 Rest of Europe Stroke Management Market by Type
5.8.1.1 Rest of Europe Diagnostics Market by Type
5.8.1.2 Rest of Europe Therapeutics Market by Type
5.8.2 Rest of Europe Stroke Management Market by Application

Chapter 6. Company Profiles
6.1 B. Braun Melsungen AG.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental Analysis
6.1.4 Research & Development Expense
6.2 Boston Scientific Corporation
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Teleflex Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental Analysis
6.3.4 Research & Development Expense
6.4 Cardinal Health
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.5 Medtronic Plc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 General Electric (GE)
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 Merck Sharp & Dohme Corp.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.8 ABBOTT
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Regional Analysis
6.8.4 Research & Development Expense
6.9 GlaxoSmithKline plc
6.9.1 Financial Analysis
6.9.2 Segmental and Regional Analysis
6.9.3 Research & Development Expense
6.1 Bristol-Myers Squibb
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Regional Analysis
6.10.4 Research & Development Expense
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Teleflex Inc.
  • Cardinal Health
  • Medtronic Plc.
  • General Electric (GE)
  • Merck Sharp & Dohme Corp.
  • ABBOTT
  • GlaxoSmithKline plc
  • Bristol-Myers Squibb.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll